ASX:AGH

Althea Group (AGH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
454,046 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Althea Group

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

AGH Stock News Headlines

Althea Group Holdings Ltd
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Althea Group Holdings Ltd Ordinary Shares
Althea Group Holdings Ltd.
I'm A Celeb's Snoochie Shy breaks down
See More Headlines
Receive AGH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Althea Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-20,990,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$28.67 million
Book Value
A$0.04 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.50
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Joshua Michael Fegan
    CEO, MD & Executive Director
  • Mr. Robert Meissner
    CFO & Company Secretary
  • Mr. David Sauer
    General Counsel

AGH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Althea Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Althea Group investors own include South32 (SOUHY), Village Roadshow Limited (VRL.AX) (VRL), Virgin Australia Holdings Limited (VAH.AX) (VAH), TubeMogul (TUBE), Sydney Airport (SYD), Orocobre (ORE), OceanaGold (OGC), Ecofibre (EOF), Clean TeQ (CLQ) and Aurora Cannabis (ACB).

This page (ASX:AGH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners